DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Emixustat

Generic Name: Emixustat

Drug Type: Small Molecule

Chemical Formula: C_₁₆H_₂₅NO_₂

CAS Number: 1141777-14-1

Unique Ingredient Identifier: 02DZ1HBF0M

Overview

Emixustat has been used in trials studying the treatment of Geographic Atrophy, Age-Related Macular Degeneration, and Dry Age-related Macular Degeneration.

Background

Emixustat has been used in trials studying the treatment of Geographic Atrophy, Age-Related Macular Degeneration, and Dry Age-related Macular Degeneration.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Safety and Efficacy of Emixustat in Stargardt Disease

Phase 3

Completed

Posted: 2018/12/11

Sponsor:

Kubota Vision Inc.

Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease

Phase 2

Completed

Posted: 2017/01/26

Sponsor:

Kubota Vision Inc.

Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy

Phase 2

Completed

Posted: 2016/04/27

Sponsor:

Kubota Vision Inc.

Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Phase 1

Completed

Posted: 2014/05/05

Sponsor:

Kubota Vision Inc.

Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride

Phase 2

Completed

Posted: 2013/03/04

Sponsor:

Kubota Vision Inc.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy